Income Statement HABA Laboratories,Inc.

Stocks

4925

JP3765130004

Personal Products

Delayed Japan Exchange Other stock markets 21:40:10 2026-07-28 EDT			5-day change	1st Jan Change
1,741.00 ^JPY	-0.40%		+0.52%	+0.64%

23-05-11	HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	CI
21-09-20	HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index	CI

da44a.pBy287fytXAdxz6m5VEwfV4p2AURoygBDDqNoUsEo7M.1n3OkvSW1B1TnlOUojN2JT12jnVU734yXQ_U6DhBm8DvMYebhrT3H2WQVQ

Published financial data: HABA LABORATORIES,INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	12.91B	12.04B	12.32B	12.06B	12.14B
Total Revenues	12.91B	12.04B	12.32B	12.06B	12.14B
Cost of Goods Sold, Total	4.11B	3.87B	3.92B	3.97B	4.05B
Gross Profit	8.79B	8.17B	8.4B	8.09B	8.09B
Selling General & Admin Expenses, Total	8.65B	8.43B	8.21B	7.4B	7.24B
Depreciation & Amortization - (IS)	461M	351M	377M	98M	131M
Other Operating Expenses, Total	9.11B	8.78B	8.59B	7.5B	7.37B
Operating Income	-317M	-609M	-187M	589M	713M
Interest Expense, Total	-7M	-6M	-9M	-17M	-16M
Interest And Investment Income	-	-	-	-	2M
Net Interest Expenses	-7M	-6M	-9M	-17M	-14M
Other Non Operating Income (Expenses)	31M	33M	4M	36M	8M
EBT, Excl. Unusual Items	-293M	-582M	-192M	608M	707M
Gain (Loss) On Sale Of Investments	-	6M	-	7M	-
Gain (Loss) On Sale Of Assets	1M	9M	-3M	-	141M
Asset Writedown	-54M	-3M	-1.65B	-	-
Other Unusual Items	79M	22M	-1M	20M	1M
EBT, Incl. Unusual Items	-267M	-548M	-1.84B	635M	849M
Income Tax Expense	2M	159M	275M	59M	89M
Earnings From Continuing Operations	-269M	-707M	-2.12B	576M	760M
Net Income to Company	-269M	-707M	-2.12B	576M	760M
Net Income - (IS)	-269M	-707M	-2.12B	576M	760M
Net Income to Common Incl Extra Items	-269M	-707M	-2.12B	576M	760M
Net Income to Common Excl. Extra Items	-269M	-707M	-2.12B	576M	760M
Per Share Items
Net EPS - Basic	-71.13	-186.96	-560.09	152.32	200.98
Basic EPS - Continuing Operations	-71.13	-186.96	-560.09	152.32	200.98
Basic Weighted Average Shares Outstanding	3.78M	3.78M	3.78M	3.78M	3.78M
Net EPS - Diluted	-71.13	-186.96	-560.09	152.32	200.98
Diluted EPS - Continuing Operations	-71.13	-186.96	-560.09	152.32	200.98
Diluted Weighted Average Shares Outstanding	3.78M	3.78M	3.78M	3.78M	3.78M
Normalized Basic EPS	-48.43	-96.19	-31.73	100.49	116.85
Normalized Diluted EPS	-48.43	-96.19	-31.73	100.49	116.85
Dividend Per Share	40	40	40	40	40
Payout Ratio	-56.13	-21.36	-7.13	26.22	19.87
Supplemental Items
EBITDA	391M	-50M	332M	747M	899M
EBITA	-317M	-609M	-187M	589M	713M
EBIT	-317M	-609M	-187M	589M	713M
Effective Tax Rate - (Ratio)	-0.75	-29.01	-14.92	9.29	10.48
Normalized Net Income	-183M	-364M	-120M	380M	442M
Supplemental Operating Expense Items
Advertising Expense	3.32B	3.1B	3.03B	2.63B	2.55B
Selling and Marketing Expenses	4.16B	3.91B	3.79B	3.31B	3.22B
Research And Development Expense From Footnotes	152M	176M	125M	117M	122M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	5.65B	4.82B	3.96B	4.74B	5.78B
Total Cash And Short Term Investments	5.65B	4.82B	3.96B	4.74B	5.78B
Accounts Receivable, Total	1.13B	975M	1.26B	1.2B	1.25B
Total Receivables	1.13B	975M	1.26B	1.2B	1.25B
Inventory	3.15B	3.37B	3.71B	2.92B	2.57B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	143M	183M	145M	175M	173M
Total Current Assets	10.07B	9.34B	9.08B	9.04B	9.78B
Net Property Plant And Equipment	4.66B	4.45B	2.96B	2.97B	2.37B
Long-term Investments	377M	308M	315M	187M	177M
Other Intangibles, Total	346M	315M	-	93M	112M
Deferred Tax Assets Long-Term	234M	235M	83M	58M	74M
Other Long-Term Assets, Total	2M	2M	2M	2M	2M
Total Assets	15.68B	14.66B	12.43B	12.34B	12.52B
Liabilities
Accounts Payable, Total	336M	475M	303M	236M	323M
Short-term Borrowings	300M	200M	600M	500M	100M
Current Portion of Long-Term Debt	785M	801M	754M	589M	480M
Current Income Taxes Payable	792M	869M	701M	943M	913M
Other Current Liabilities	318M	453M	455M	390M	530M
Total Current Liabilities	2.53B	2.8B	2.81B	2.66B	2.35B
Long-Term Debt	1.47B	1.03B	1B	727M	607M
Deferred Tax Liability Non Current	-	-	50M	2M	-
Other Non Current Liabilities	46M	54M	62M	30M	30M
Total Liabilities	4.05B	3.88B	3.92B	3.42B	2.98B
Common Stock, Total	696M	696M	696M	696M	696M
Additional Paid In Capital	812M	812M	812M	812M	812M
Retained Earnings	11.26B	10.4B	8.13B	8.55B	9.16B
Treasury Stock	-1.14B	-1.14B	-1.14B	-1.14B	-1.14B
Comprehensive Income and Other	6M	1M	5M	1M	1M
Total Common Equity	11.64B	10.77B	8.51B	8.93B	9.54B
Total Equity	11.64B	10.77B	8.51B	8.93B	9.54B
Total Liabilities And Equity	15.68B	14.66B	12.43B	12.34B	12.52B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.78M	3.78M	3.78M	3.78M	3.78M
ECS Total Common Shares Outstanding	3.78M	3.78M	3.78M	3.78M	3.78M
Book Value / Share	3.08K	2.85K	2.25K	2.36K	2.52K
Tangible Book Value	11.29B	10.46B	8.51B	8.83B	9.42B
Tangible Book Value Per Share	2.99K	2.77K	2.25K	2.34K	2.49K
Total Debt	2.56B	2.03B	2.35B	1.82B	1.19B
Net Debt	-3.09B	-2.78B	-1.6B	-2.93B	-4.6B
Inventories - Raw Materials, Total	1.84B	1.89B	1.83B	1.49B	1.18B
Inventories - Work In Process, Total	28M	69M	25M	35M	23M
Inventories - Finished Goods, Total	1.28B	1.41B	1.85B	1.4B	1.37B
Inventories - Others	1M	1M	2M	1M	1M
Full Time Employees	673	654	631	568	523
Accumulated Allowance for Doubtful Accounts (Supple)	20M	12M	13M	12M	11M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	-266M	-548M	-1.84B	635M	850M
Depreciation & Amortization - CF	708M	559M	519M	158M	186M
Depreciation & Amortization, Total	708M	559M	519M	158M	186M
(Gain) Loss From Sale Of Asset	52M	-5M	1.65B	-	-130M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-7M	-
Other Operating Activities, Total	264M	68M	-223M	4M	-84M
Change In Accounts Receivable	93M	142M	-284M	72M	-56M
Change In Inventories	883M	-216M	-344M	791M	350M
Change In Accounts Payable	29M	114M	-167M	-71M	138M
Change in Other Net Operating Assets	-49M	-59M	104M	39M	-17M
Cash from Operations	1.71B	55M	-587M	1.62B	1.24B
Capital Expenditure	-124M	-191M	-154M	-138M	-77M
Sale of Property, Plant, and Equipment	8M	30M	18M	-	654M
Sale (Purchase) of Intangible assets	-63M	-97M	-278M	-73M	-32M
Investment in Marketable and Equity Securities, Total	-	-	-	11M	-100M
Other Investing Activities, Total	-37M	44M	-27M	53M	39M
Cash from Investing	-216M	-214M	-441M	-147M	484M
Short Term Debt Issued, Total	-	-	400M	-	-
Long-Term Debt Issued, Total	400M	400M	800M	400M	400M
Total Debt Issued	400M	400M	1.2B	400M	400M
Short Term Debt Repaid, Total	-800M	-100M	-	-100M	-400M
Long-Term Debt Repaid, Total	-961M	-825M	-877M	-838M	-629M
Total Debt Repaid	-1.76B	-925M	-877M	-938M	-1.03B
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-151M	-151M	-151M	-151M	-151M
Common & Preferred Stock Dividends Paid	-151M	-151M	-151M	-151M	-151M
Other Financing Activities, Total	-	-	-1M	-	-
Cash from Financing	-1.51B	-676M	171M	-689M	-780M
Foreign Exchange Rate Adjustments	2M	1M	-	-	-
Miscellaneous Cash Flow Adjustments	-	1M	-1M	-1M	-1M
Net Change in Cash	-12M	-833M	-858M	784M	940M
Supplemental Items
Cash Interest Paid	6M	5M	9M	17M	17M
Cash Income Tax Paid (Refund)	-154M	-6M	228M	23M	93M
Levered Free Cash Flow	1.55B	132M	-964M	1.24B	1.01B
Unlevered Free Cash Flow	1.55B	135M	-959M	1.25B	1.02B
Change In Net Working Capital	-1.23B	-245M	929M	-935M	-493M
Net Debt Issued / Repaid	-1.36B	-525M	323M	-538M	-629M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	-1.2	-2.51	-0.86	2.97	3.58
Return on Total Capital	-1.31	-2.82	-0.99	3.41	4.15
Return On Equity %	-2.27	-6.31	-21.97	6.61	8.23
Return on Common Equity	-2.27	-6.31	-21.97	6.61	8.23
Margin Analysis
Gross Profit Margin %	68.13	67.86	68.19	67.09	66.61
SG&A Margin	67.01	70	66.65	61.4	59.66
EBITDA Margin %	3.03	-0.42	2.69	6.19	7.4
EBITA Margin %	-2.46	-5.06	-1.52	4.88	5.87
EBIT Margin %	-2.46	-5.06	-1.52	4.88	5.87
Income From Continuing Operations Margin %	-2.08	-5.87	-17.19	4.78	6.26
Net Income Margin %	-2.08	-5.87	-17.19	4.78	6.26
Net Avail. For Common Margin %	-2.08	-5.87	-17.19	4.78	6.26
Normalized Net Income Margin	-1.42	-3.02	-0.97	3.15	3.64
Levered Free Cash Flow Margin	11.99	1.09	-7.83	10.28	8.28
Unlevered Free Cash Flow Margin	12.02	1.12	-7.78	10.36	8.37
Asset Turnover
Asset Turnover	0.78	0.79	0.91	0.97	0.98
Fixed Assets Turnover	2.67	2.64	3.33	4.07	4.54
Receivables Turnover (Average Receivables)	11.1	11.46	11.03	9.83	9.92
Inventory Turnover (Average Inventory)	1.15	1.19	1.11	1.2	1.48
Short Term Liquidity
Current Ratio	3.98	3.34	3.23	3.4	4.17
Quick Ratio	2.68	2.07	1.85	2.23	3
Operating Cash Flow to Current Liabilities	0.68	0.02	-0.21	0.61	0.53
Days Sales Outstanding (Average Receivables)	32.89	31.85	33.17	37.15	36.81
Days Outstanding Inventory (Average Inventory)	318.73	307.5	330.57	305.04	247.19
Average Days Payable Outstanding	36.49	36.22	33.38	30.96	27.55
Cash Conversion Cycle (Average Days)	315.13	303.13	330.36	311.23	256.45
Long Term Solvency
Total Debt/Equity	21.97	18.86	27.67	20.34	12.45
Total Debt / Total Capital	18.02	15.87	21.68	16.9	11.07
LT Debt/Equity	12.65	9.57	11.76	8.14	6.37
Long-Term Debt / Total Capital	10.37	8.05	9.21	6.77	5.66
Total Liabilities / Total Assets	25.81	26.5	31.57	27.68	23.83
EBIT / Interest Expense	-45.29	-101.5	-20.78	34.65	44.56
EBITDA / Interest Expense	55.86	-8.33	36.89	43.94	56.19
(EBITDA - Capex) / Interest Expense	38.14	-40.17	19.78	35.82	51.38
Total Debt / EBITDA	6.54	-40.64	7.09	2.43	1.32
Net Debt / EBITDA	-7.91	55.7	-4.83	-3.92	-5.11
Total Debt / (EBITDA - Capex)	9.58	-8.43	13.22	2.98	1.44
Net Debt / (EBITDA - Capex)	-11.59	11.56	-9.02	-4.81	-5.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-9.78	-6.74	2.38	-2.13	0.66
Gross Profit, 1 Yr. Growth %	-13.78	-7.11	2.88	-3.71	-0.06
EBITDA, 1 Yr. Growth %	-56.36	-112.79	-764	125	20.35
EBITA, 1 Yr. Growth %	-239.65	92.11	-69.29	-414.97	21.05
EBIT, 1 Yr. Growth %	-239.65	92.11	-69.29	-414.97	21.05
Earnings From Cont. Operations, 1 Yr. Growth %	-224.54	162.83	199.58	-127.2	31.94
Net Income, 1 Yr. Growth %	-224.54	162.83	199.58	-127.2	31.94
Normalized Net Income, 1 Yr. Growth %	-217.2	98.63	-67.01	-416.67	16.28
Diluted EPS Before Extra, 1 Yr. Growth %	-224.54	162.83	199.58	-127.2	31.95
Accounts Receivable, 1 Yr. Growth %	-6.17	-13.41	29.13	-5	4.77
Inventory, 1 Yr. Growth %	-21.89	6.89	10.24	-21.33	-12.02
Net Property, Plant and Equip., 1 Yr. Growth %	-6.96	-4.36	-33.63	0.47	-20.04
Total Assets, 1 Yr. Growth %	-10.07	-6.57	-15.18	-0.7	1.42
Tangible Book Value, 1 Yr. Growth %	-1.96	-7.38	-18.66	3.86	6.68
Common Equity, 1 Yr. Growth %	-3.34	-7.43	-21.04	4.95	6.82
Cash From Operations, 1 Yr. Growth %	220.97	-96.79	-1.17K	-376.15	-23.69
Capital Expenditures, 1 Yr. Growth %	-84.42	54.03	-19.37	-10.39	-44.2
Levered Free Cash Flow, 1 Yr. Growth %	-414.85	-91.49	-832.76	-228.51	-18.87
Unlevered Free Cash Flow, 1 Yr. Growth %	-418.58	-91.28	-808.31	-230.37	-18.76
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-16.17	-8.27	-2.29	0.1	-0.75
Gross Profit, 2 Yr. CAGR %	-19.78	-10.5	-2.24	-0.47	-1.9
EBITDA, 2 Yr. CAGR %	-61.43	-76.38	-7.85	286.52	64.55
EBITA, 2 Yr. CAGR %	-60.17	63.79	-23.19	-1.66	95.26
EBIT, 2 Yr. CAGR %	-60.17	63.79	-23.19	-1.66	95.26
Earnings From Cont. Operations, 2 Yr. CAGR %	-54.74	80.92	180.6	-9.74	-40.1
Net Income, 2 Yr. CAGR %	-54.74	80.92	180.6	-9.74	-40.1
Normalized Net Income, 2 Yr. CAGR %	-61.48	52.58	-19.05	2.21	91.89
Diluted EPS Before Extra, 2 Yr. CAGR %	-54.21	80.92	180.6	-9.74	-40.1
Accounts Receivable, 2 Yr. CAGR %	-11.01	-9.86	5.74	10.76	-0.24
Inventory, 2 Yr. CAGR %	-13.98	-8.63	8.55	-6.87	-16.8
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.6	-5.67	-20.33	-18.34	-10.37
Total Assets, 2 Yr. CAGR %	-4.2	-8.33	-10.98	-8.22	0.35
Tangible Book Value, 2 Yr. CAGR %	0.34	-4.71	-13.2	-8.09	5.26
Common Equity, 2 Yr. CAGR %	-1.41	-5.4	-14.5	-8.97	5.88
Cash From Operations, 2 Yr. CAGR %	59.35	-67.91	-41.48	442.89	45.17
Capital Expenditures, 2 Yr. CAGR %	-56.32	-51.02	11.44	-15	-29.29
Levered Free Cash Flow, 2 Yr. CAGR %	148.3	-48.25	-21.05	206.87	2.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	150.53	-47.28	-21.39	203.88	2.92
Dividend Per Share, 2 Yr. CAGR %	0	0	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-12.48	-13.14	-4.85	-2.24	0.28
Gross Profit, 3 Yr. CAGR %	-15.38	-15.76	-6.25	-2.74	-0.34
EBITDA, 3 Yr. CAGR %	-52.77	-73.3	-28.17	24.08	161.98
EBITA, 3 Yr. CAGR %	-53.21	-32.7	-6.26	22.94	5.4
EBIT, 3 Yr. CAGR %	-53.21	-32.7	-6.26	22.94	5.4
Earnings From Cont. Operations, 3 Yr. CAGR %	-49.49	-18.64	114.04	28.89	2.44
Net Income, 3 Yr. CAGR %	-49.49	-18.64	114.04	28.89	2.44
Normalized Net Income, 3 Yr. CAGR %	-54.44	-33.45	-8.42	27.55	6.7
Diluted EPS Before Extra, 3 Yr. CAGR %	-48.83	-18.01	114.04	28.89	2.44
Accounts Receivable, 3 Yr. CAGR %	-17.01	-11.82	1.61	2.03	8.72
Inventory, 3 Yr. CAGR %	2.83	-7.52	-2.73	-2.49	-8.62
Net Property, Plant and Equip., 3 Yr. CAGR %	1.47	-1.87	-16.1	-13.92	-18.91
Total Assets, 3 Yr. CAGR %	-1.66	-5	-10.67	-7.67	-5.12
Tangible Book Value, 3 Yr. CAGR %	0.1	-2.3	-9.61	-7.85	-3.41
Common Equity, 3 Yr. CAGR %	-0.89	-3.46	-10.93	-8.46	-3.98
Cash From Operations, 3 Yr. CAGR %	-3.73	-56.65	3.2	-1.84	182.27
Capital Expenditures, 3 Yr. CAGR %	-25.67	-33.52	-42.16	3.63	-26.13
Levered Free Cash Flow, 3 Yr. CAGR %	5.17	-19.36	25.2	-7.13	96.95
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.14	-18.19	25.33	-6.95	95.76
Dividend Per Share, 3 Yr. CAGR %	0	0	0	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-4.36	-7.61	-8.54	-8.07	-3.23
Gross Profit, 5 Yr. CAGR %	-6.2	-9.34	-10.35	-9.95	-4.53
EBITDA, 5 Yr. CAGR %	-29.88	-55.95	-38.29	-22.24	0.07
EBITA, 5 Yr. CAGR %	-29.1	-23.99	-42.95	-21.67	25.72
EBIT, 5 Yr. CAGR %	-29.1	-23.99	-42.95	-21.67	25.72
Earnings From Cont. Operations, 5 Yr. CAGR %	-26.01	-15.04	0.29	-15.19	28.61
Net Income, 5 Yr. CAGR %	-26.01	-15.04	0.29	-15.19	28.61
Normalized Net Income, 5 Yr. CAGR %	-30.03	-24.61	-42.67	-20.99	23.11
Diluted EPS Before Extra, 5 Yr. CAGR %	-25.42	-14.37	1.08	-14.8	28.61
Accounts Receivable, 5 Yr. CAGR %	-6.99	-12.43	-8.57	-3.4	0.87
Inventory, 5 Yr. CAGR %	5.51	8.03	5.08	-7.26	-8.62
Net Property, Plant and Equip., 5 Yr. CAGR %	0.95	-1.04	-7.89	-8.82	-13.85
Total Assets, 5 Yr. CAGR %	3.03	-0.85	-5.5	-6.3	-6.42
Tangible Book Value, 5 Yr. CAGR %	7.61	2.57	-5.45	-4.66	-3.93
Common Equity, 5 Yr. CAGR %	6.47	1.53	-6.57	-5.7	-4.55
Cash From Operations, 5 Yr. CAGR %	2.77	-54	-21.11	19.15	18.29
Capital Expenditures, 5 Yr. CAGR %	-24.87	-22.27	-12.6	-26.65	-37.32
Levered Free Cash Flow, 5 Yr. CAGR %	35.64	-40.18	-6.23	37.63	15.39
Unlevered Free Cash Flow, 5 Yr. CAGR %	34.45	-39.92	-6.41	38.28	15.83
Dividend Per Share, 5 Yr. CAGR %	5.92	5.92	0	0	0